Cannabis Co. Cresco Lab’s Q2 Gross Profit Increases Over 9% YoY, Reports Nearly 7% Drop In Revenue
Cannabis producer and operator of Sunnyside dispensaries, Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) released its financial and operating results Thursday for the second quarter ended June 30, 2024.
“Our Q2 results demonstrate the sustainability of the improvements we’ve made to the business over the past year with $184 million in revenue at a 29% Adjusted EBITDA margin,” said CEO Charles Bachtell. “It is clear our strategy is working; we are creating the brands consumers love and delivering best-in-class retail operations through Sunnyside.”